Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin

Nazira Mahmut, Kaoru Inoue, Yukako Fujinaga, Lynn Hughes, Hideyuki Arimitsu, Yoshihiko Sakaguchi, Aiji Ohtsuka, Takuro Murakami, Kenji Yokota, Keiji Oguma

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Of 11 monoclonal antibodies (MAbs) prepared against the non-toxic component of type C Clostridium botulinum 16S toxin to clarify the function of the non-toxic component, seven recognised HA1, three recognised HA3b and one recognised HA2. Results of epitope mapping indicated that three of the seven anti-HA1 MAbs recognised the region between amino acid residues 121 and 140 and four recognised the three-dimensional structure of HA1. Three anti-HA3b MAbs recognised different regions between (approximately) amino acids 405-430, 180-270 and 275-297. The ability of these MAbs to interfere with binding of 16S toxin or non-toxic component, HA1 or HA3b to erythrocytes and to intestine tissue sections of guinea-pig was observed. MAbs against HA3b and HA2 did not inhibit 16S toxin binding to either erythrocytes or epithelial cells, whereas some MAbs against HA1 did inhibit binding. The seven anti-HA1 MAbs can be classified into four groups based on their binding inhibition activities. The anti-HA1 MAbs that inhibited the binding of 16S toxin to the epithelial cells also neutralised or reduced the oral toxicity in mice, indicating that HA may play an important role in the absorption of the 16S toxin from the small intestine.

Original languageEnglish
Pages (from-to)286-294
Number of pages9
JournalJournal of Medical Microbiology
Volume51
Issue number4
Publication statusPublished - 2002

Fingerprint

Clostridium botulinum type C
Neurotoxins
Hemagglutinins
Monoclonal Antibodies
Erythrocytes
Epithelial Cells
Epitope Mapping
Amino Acids
Small Intestine
Intestines
Guinea Pigs

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Mahmut, N., Inoue, K., Fujinaga, Y., Hughes, L., Arimitsu, H., Sakaguchi, Y., ... Oguma, K. (2002). Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin. Journal of Medical Microbiology, 51(4), 286-294.

Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin. / Mahmut, Nazira; Inoue, Kaoru; Fujinaga, Yukako; Hughes, Lynn; Arimitsu, Hideyuki; Sakaguchi, Yoshihiko; Ohtsuka, Aiji; Murakami, Takuro; Yokota, Kenji; Oguma, Keiji.

In: Journal of Medical Microbiology, Vol. 51, No. 4, 2002, p. 286-294.

Research output: Contribution to journalArticle

Mahmut, N, Inoue, K, Fujinaga, Y, Hughes, L, Arimitsu, H, Sakaguchi, Y, Ohtsuka, A, Murakami, T, Yokota, K & Oguma, K 2002, 'Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin', Journal of Medical Microbiology, vol. 51, no. 4, pp. 286-294.
Mahmut, Nazira ; Inoue, Kaoru ; Fujinaga, Yukako ; Hughes, Lynn ; Arimitsu, Hideyuki ; Sakaguchi, Yoshihiko ; Ohtsuka, Aiji ; Murakami, Takuro ; Yokota, Kenji ; Oguma, Keiji. / Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin. In: Journal of Medical Microbiology. 2002 ; Vol. 51, No. 4. pp. 286-294.
@article{f777b159e81747e38ce640b67c526a82,
title = "Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin",
abstract = "Of 11 monoclonal antibodies (MAbs) prepared against the non-toxic component of type C Clostridium botulinum 16S toxin to clarify the function of the non-toxic component, seven recognised HA1, three recognised HA3b and one recognised HA2. Results of epitope mapping indicated that three of the seven anti-HA1 MAbs recognised the region between amino acid residues 121 and 140 and four recognised the three-dimensional structure of HA1. Three anti-HA3b MAbs recognised different regions between (approximately) amino acids 405-430, 180-270 and 275-297. The ability of these MAbs to interfere with binding of 16S toxin or non-toxic component, HA1 or HA3b to erythrocytes and to intestine tissue sections of guinea-pig was observed. MAbs against HA3b and HA2 did not inhibit 16S toxin binding to either erythrocytes or epithelial cells, whereas some MAbs against HA1 did inhibit binding. The seven anti-HA1 MAbs can be classified into four groups based on their binding inhibition activities. The anti-HA1 MAbs that inhibited the binding of 16S toxin to the epithelial cells also neutralised or reduced the oral toxicity in mice, indicating that HA may play an important role in the absorption of the 16S toxin from the small intestine.",
author = "Nazira Mahmut and Kaoru Inoue and Yukako Fujinaga and Lynn Hughes and Hideyuki Arimitsu and Yoshihiko Sakaguchi and Aiji Ohtsuka and Takuro Murakami and Kenji Yokota and Keiji Oguma",
year = "2002",
language = "English",
volume = "51",
pages = "286--294",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",
number = "4",

}

TY - JOUR

T1 - Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin

AU - Mahmut, Nazira

AU - Inoue, Kaoru

AU - Fujinaga, Yukako

AU - Hughes, Lynn

AU - Arimitsu, Hideyuki

AU - Sakaguchi, Yoshihiko

AU - Ohtsuka, Aiji

AU - Murakami, Takuro

AU - Yokota, Kenji

AU - Oguma, Keiji

PY - 2002

Y1 - 2002

N2 - Of 11 monoclonal antibodies (MAbs) prepared against the non-toxic component of type C Clostridium botulinum 16S toxin to clarify the function of the non-toxic component, seven recognised HA1, three recognised HA3b and one recognised HA2. Results of epitope mapping indicated that three of the seven anti-HA1 MAbs recognised the region between amino acid residues 121 and 140 and four recognised the three-dimensional structure of HA1. Three anti-HA3b MAbs recognised different regions between (approximately) amino acids 405-430, 180-270 and 275-297. The ability of these MAbs to interfere with binding of 16S toxin or non-toxic component, HA1 or HA3b to erythrocytes and to intestine tissue sections of guinea-pig was observed. MAbs against HA3b and HA2 did not inhibit 16S toxin binding to either erythrocytes or epithelial cells, whereas some MAbs against HA1 did inhibit binding. The seven anti-HA1 MAbs can be classified into four groups based on their binding inhibition activities. The anti-HA1 MAbs that inhibited the binding of 16S toxin to the epithelial cells also neutralised or reduced the oral toxicity in mice, indicating that HA may play an important role in the absorption of the 16S toxin from the small intestine.

AB - Of 11 monoclonal antibodies (MAbs) prepared against the non-toxic component of type C Clostridium botulinum 16S toxin to clarify the function of the non-toxic component, seven recognised HA1, three recognised HA3b and one recognised HA2. Results of epitope mapping indicated that three of the seven anti-HA1 MAbs recognised the region between amino acid residues 121 and 140 and four recognised the three-dimensional structure of HA1. Three anti-HA3b MAbs recognised different regions between (approximately) amino acids 405-430, 180-270 and 275-297. The ability of these MAbs to interfere with binding of 16S toxin or non-toxic component, HA1 or HA3b to erythrocytes and to intestine tissue sections of guinea-pig was observed. MAbs against HA3b and HA2 did not inhibit 16S toxin binding to either erythrocytes or epithelial cells, whereas some MAbs against HA1 did inhibit binding. The seven anti-HA1 MAbs can be classified into four groups based on their binding inhibition activities. The anti-HA1 MAbs that inhibited the binding of 16S toxin to the epithelial cells also neutralised or reduced the oral toxicity in mice, indicating that HA may play an important role in the absorption of the 16S toxin from the small intestine.

UR - http://www.scopus.com/inward/record.url?scp=0036201088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036201088&partnerID=8YFLogxK

M3 - Article

C2 - 11926732

AN - SCOPUS:0036201088

VL - 51

SP - 286

EP - 294

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

IS - 4

ER -